Vicky Patil

Managing Director

The Indian pharmaceutical market, poised for remarkable growth, is anticipated to reach $65 billion by 2024, demonstrating a robust CAGR of 10 percent. This projection underscores the crucial role pharmaceutical formulation manufacturers’ play in the healthcare sector. Pharmaceutical formulation manufacturers play a crucial role within the healthcare sector, encompassing the development, production, and distribution of diverse drug formulations such as tablets, capsules, injections, creams, and other medical solutions.

These manufacturers are dedicated to guaranteeing the effectiveness, safety, and quality of pharmaceutical products by following strict regulatory guidelines and utilizing state-of-the-art technologies during the manufacturing process. Some of the recent advancements in this industry comprise the integration of advanced drug delivery techniques such as nanotechnology and biopharmaceuticals, a growing emphasis on personalized treatments, combined with a strong commitment to sustainability & environmentally friendly production methods.

However, amidst these advancements, manufacturers encounter notable challenges, including rigorous compliance with evolving regulatory frameworks, escalating production costs, disruptions within the global supply chain, intensifying market competition, and the critical imperative to swiftly adapt to evolving research and technological breakthroughs, all while maintaining the affordability and accessibility of essential medications for patients. Dortmund Laboratories stands out from the other players as a prominent problem-solver in this challenging climate with a mission to manufacture, sell, as well as export high-quality drugs, primarily through Effervescent Technology in Nutraceuticals and Pharmaceuticals.

Redefining Pharmaceutical Excellence through Effervescent Innovation

Established in 1987 under the Companies Act 1956, Dortmund Laboratories is a privately owned pharmaceutical manufacturing company with a steadfast focus on international quality. Vicky Patil, the MD, leads the company with 34 years of expertise in pharmaceutical formulations and healthcare products, excelling in manufacturing generic formulations such as tablets, capsules, ointments, and liquids. Established with the goal of producing, selling, and exporting high-quality medications, Dortmund Laboratories focuses on utilising effervescent technology in both pharmaceuticals and nutraceuticals landscape. “We are dedicated to serving humanity, boasting a team of highly qualified professionals with rich experience. Our vision emphasizes upholding social responsibilities by delivering superior healthcare services while adhering to core values of integrity, ethics, and commitment”, affirms Vicky Patil, Managing Director.

The firm aspires to become a globally acclaimed effervescent pharmaceutical company by expanding its portfolio of effervescent products. The company maintains stringent standards, being ISO 22000:2018 certified and WHO – GMP accredited. Dortmund Laboratories continually pushes beyond complacency, striving for continuous improvement, and showcasing its commitment to excellence through associations with esteemed organizations like Pharmexcil, Chemexcil, and FIEO, ensuring top-notch quality and service for its clientele.

To satisfy the various needs of its clientele, the company provides a wide array of pharmaceutical goods and services. OTC Products, Pharma Products, and different Value-Added Products are all included in the company's product line. Operating from a cutting-edge manufacturing facility, the company boasts fully automated processes, validated procedures, state-of-the-art technology, and rigorous adherence to Quality Management systems, compliant with both National and International regulatory standards.

This infrastructure ensures Dortmund's ability to deliver superior quality products within stipulated timelines. With a specialization in solid dosage forms such as effervescent tablets and powder granules, Dortmund Laboratories emphasizes environmental sustainability by manufacturing pharmaceutical products that are environmentally friendly and advocating for initiatives aimed at achieving defect-free manufacturing and packaging. “Our core focus revolves around providing an extensive range of finished formulations utilizing effervescent technology, with a specific emphasis on meticulously designed effervescent tablets capable of accommodating significant ingredient doses in a single serving. These tablets combine organic food with acid-alkaline sources, forming salts that buffer the solution to a normal pH, ensuring gastric comfort and expediting ingredient absorption into the bloodstream, as validated by clinical studies”, adds Vicky Patil.

Quality & Future Expansion through Strategic Quality Management

Dortmund Laboratories has established a stringent and meticulously designed Quality Management System (QMS) in full compliance with both national and international regulatory standards. Accredited and certified by WHO - GMP and various regulatory bodies across different countries, the QMS is subject to periodic reviews to ensure its ongoing relevance and effectiveness. Updates and adjustments are made as per the latest applicable guidelines, reflecting the company's commitment to maintaining the highest levels of quality. “We prioritize comprehensive training programs for GMP, GLP, Documentation Control, IPQA, IPQC, stability evaluation, Change Control, Deviation Management, APQR, QRM, and safety regulations”, says Vicky Patil.

When engaging with clients, the company initiates the process upon receiving a product inquiry, progressing through commercial agreements and subsequent Indian FDA document procedures. In regions where product registration is not obligatory, processes such as packaging printing and raw material procurement commence post- Indian FDA documentation. The company is dedicated to following regulations and aligning with them throughout all client interactions, in accordance with the overseas market's regulatory requirements for GMP inspection and product registration procedures.

The firm envisions a strategic roadmap, aiming for a significant expansion of its product portfolio. The firm plans to diversify finished formulation dosages with multi-ingredient incorporation, particularly emphasizing effervescent technology. This reflects its commitment to innovation and market adaptability. Additionally, Dortmund is preparing for stringent international Ministry of Health (MOH) site visits, focusing on its effervescent manufacturing facility. Anticipated visits from countries like Nigeria, Ghana, Uganda, Ivory Coast, and Ethiopia underscore its dedication to global pharmaceutical manufacturing standards. As a leader in Effervescent Technology Pharmaceutical products, Dortmund aims to set new industry benchmarks, cementing its leadership.